Lead party: Tuninvest Finance Group (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Les Laboratoires MédiS,
Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Ordinary Shares (Equity) · Equity stake: 0.0945% · Fund: Tuninvest SICAR
Investors/buyers: Tuninvest Finance Group
Legal advisers: not identified in the source record.
Source: announced 1 January 1996. Original announcement: cmf.tn.


